Literature DB >> 11138005

A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.

K Zhang1, M Kniazeva, M Han, W Li, Z Yu, Z Yang, Y Li, M L Metzker, R Allikmets, D J Zack, L E Kakuk, P S Lagali, P W Wong, I M MacDonald, P A Sieving, D J Figueroa, C P Austin, R J Gould, R Ayyagari, K Petrukhin.   

Abstract

Stargardt-like macular dystrophy (STGD3, MIM 600110) and autosomal dominant macular dystrophy (adMD) are inherited forms of macular degeneration characterized by decreased visual acuity, macular atrophy and extensive fundus flecks. Genetic mapping data suggest that mutations in a single gene may be responsible for both conditions, already known to bear clinical resemblance. Here we limit the minimum genetic region for STGD3 and adMD to a 0.6-cM interval by recombination breakpoint mapping and identify a single 5-bp deletion within the protein-coding region of a new retinal photoreceptor-specific gene, ELOVL4, in all affected members of STGD3 and adMD families. Bioinformatic analysis of ELOVL4 revealed that it has homology to a group of yeast proteins that function in the biosynthesis of very long chain fatty acids. Our results are therefore the first to implicate the biosynthesis of fatty acids in the pathogenesis of inherited macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11138005     DOI: 10.1038/83817

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  171 in total

1.  Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Authors:  John W Crabb; Masaru Miyagi; Xiaorong Gu; Karen Shadrach; Karen A West; Hirokazu Sakaguchi; Motohiro Kamei; Azeem Hasan; Lin Yan; Mary E Rayborn; Robert G Salomon; Joe G Hollyfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

2.  Effect of docosahexaenoic acid supplementation on retinal function in a patient with autosomal dominant Stargardt-like retinal dystrophy.

Authors:  I M MacDonald; M Hébert; R J Yau; S Flynn; J Jumpsen; M Suh; M T Clandinin
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

3.  Genetics and ARMD.

Authors:  Ian M MacDonald; Matthew A Lines
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

Review 4.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

5.  Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration.

Authors:  Aihua Liu; James Chang; Yanhua Lin; Zhengqing Shen; Paul S Bernstein
Journal:  J Lipid Res       Date:  2010-08-05       Impact factor: 5.922

Review 6.  Retinoids for treatment of retinal diseases.

Authors:  Krzysztof Palczewski
Journal:  Trends Pharmacol Sci       Date:  2010-06       Impact factor: 14.819

Review 7.  Retinal remodeling.

Authors:  B W Jones; M Kondo; H Terasaki; Y Lin; M McCall; R E Marc
Journal:  Jpn J Ophthalmol       Date:  2012-05-30       Impact factor: 2.447

8.  Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration.

Authors:  G Karan; C Lillo; Z Yang; D J Cameron; K G Locke; Y Zhao; S Thirumalaichary; C Li; D G Birch; H R Vollmer-Snarr; D S Williams; K Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-04       Impact factor: 11.205

9.  Elovl4 and Fa2h expression during rat spermatogenesis: a link to the very-long-chain PUFAs typical of germ cell sphingolipids.

Authors:  Florencia X Santiago Valtierra; Daniel A Peñalva; Jessica M Luquez; Natalia E Furland; Claudia Vásquez; Juan G Reyes; Marta I Aveldaño; Gerardo M Oresti
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

10.  A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines.

Authors:  Anne McMahon; Shelley N Jackson; Amina S Woods; Wojciech Kedzierski
Journal:  FEBS Lett       Date:  2007-11-05       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.